ALS Drugs Now: Columbia University’s Emily Lowry Excels at ALS Drug Screening Technique

On March 8, Project ALS and Women and the Brain awarded $60k to post-doctoral fellow Emily Lowry, who is using iPS and other stem cell models of human ALS in a new way to discover drugs of interest to patients. Dr. Lowry, who works in the laboratory of long-time Project ALS collaborator, Hynek Wichterle, has devised a panel of “assays’—or mini representations of human ALS—to identify a new therapeutic pathway in the disease. Thanks to Dr. Lowry’s ingenuity and persistence, Project ALS is working with academic and drug company experts to identify drugs that might hit that pathway and provide new options for patients.